GPCR40 agonist (Janssen Research and Development)

N/A

Report date: 2025/03/20 15:22:45
NME

Base Information

Drug NameGPCR40 agonist (Janssen Research and Development)
Drug Alias NameGPR40 agonist (Janssen Research and Development)G-protein coupled receptor 40 agonist (Janssen Research and Development)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor agonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Research & Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A